2-Tridecyloxy-ethylamine | 38471-32-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-Tridecyloxy-ethylamine
• 英文别名: Tridecyloxyethylamine；2-tridecoxyethanamine
• CAS: 38471-32-8
• 化学式: C₁₅H₃₃NO
• 分子量: 243.433
• InChiKey: DRKDXFYLSKQUKM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  17
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] OPIOID AGONISTS AND USES THEREOF<br/>[FR] AGONISTES OPIOÏDES ET LEURS UTILISATIONS
  申请人：NEKTAR THERAPEUTICS INDIA PVT LTD

  公开号：WO2015079459A1

  公开（公告）日：2015-06-04

  Provided are compounds, including those of Formula I; and pharmaceutically acceptable salts and solvates thereof. The compounds described herein relate to and/or have application(s) in (among others) the fields of drug discovery, pharmacotherapy, physiology, organic chemistry and polymer chemistry.

  提供的是化合物，包括公式I的化合物；以及它们的药用可接受盐和溶剂化物。本文所述的化合物与药物发现、药物治疗、生理学、有机化学和聚合物化学等领域有关，并且/或在这些领域有应用。
• Process for preparing 1,3-disubstituted urea
  申请人：SUMIKA FINE CHEMICALS Co., Ltd.

  公开号：EP0846679A2

  公开（公告）日：1998-06-10

  Process for preparing 1,3-disubstituted urea of the formula: wherein R5 is the same as or different from R6, and each of R5 and R6 is independently linear or branched, alkyl of 1-20 carbon atoms, alkenyl group having 2 to 20 carbon atoms or alkynyl group having 2 to 20 carbon atoms, which may have phenoxy, alkoxy of 1-13 carbon atoms, monocycloalkyl of 3-8 carbon atoms, bicycloalkyl of 6-12 carbon atoms, aryl of 6-13 carbon atoms, furyl, pyridyl, or aralkyl of 7-20 carbon atoms, comprising reacting cyclic carbonic acid ester with an amine using alkali metal alkoxide or trialkylamine as base, in safety and high yield.

  制备式 1，3-二取代脲的工艺： 其中 R5 与 R6 相同或不同，R5 和 R6 各自独立地为 1-20 个碳原子的直链或支链烷基、具有 2-20 个碳原子的烯基或具有 2-20 个碳原子的炔基，它们可以具有苯氧基、1-13 个碳原子的烷氧基、3-8 个碳原子的单环烷基、6-12 个碳原子的双环烷基、6-13 个碳原子的芳基、3-8 个碳原子的单环烷基、6-12 个碳原子的双环烷基、6-13 个碳原子的芳基、7-20 个碳原子的呋喃基、吡啶基或芳烷基，包括以碱金属氧化物或三烷基胺为碱，使环状碳酸酯与胺反应，安全且收率高。
• LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT
  申请人：JNC Corporation

  公开号：EP3275973A1

  公开（公告）日：2018-01-31

  Subject The subject is to provide a liquid crystal composition that includes a polymerizable compound (or polymer) and a polar compound, where the homeotropic alignment of liquid crystal molecules can be achieved by the action of these compounds, and a liquid crystal display device including this composition. This composition satisfies at least one of characteristics such as a high maximum temperature, a low minimum temperature, a small viscosity, a suitable optical anisotropy, a large positive dielectric anisotropy, a large specific resistance, a high stability to ultraviolet light or heat or a large elastic constant, or is suitably balanced regarding at least two of the characteristics. The means concerns a nematic liquid crystal composition that has positive dielectric anisotropy and that includes a polymerizable compound as an first additive and a polar compound as a second additive, and the composition may include a specific liquid crystal compound having a large positive dielectric anisotropy and a specific liquid crystal compound having a high maximum temperature or a small viscosity, and concerns a liquid crystal display device including the composition.

  主题 本课题旨在提供一种液晶组合物，其中包括一种可聚合化合物（或聚合物）和一种极性化合物，通过这些化合物的作用可实现液晶分子的各向同性排列，并提供一种包括这种组合物的液晶显示装置。这种组合物至少满足以下一种特性，如最高温度高、最低温度低、粘度小、光学各向异性合适、正介电各向异性大、比电阻大、对紫外线或热的稳定性高或弹性常数大，或至少在其中两种特性方面适当平衡。 该手段涉及一种具有正介电常数的向列液晶组合物，该组合物包括作为第一添加剂的可聚合化合物和作为第二添加剂的极性化合物，该组合物可包括具有较大正介电常数的特定液晶化合物和具有较高最高温度或较小粘度的特定液晶化合物，还涉及一种包括该组合物的液晶显示设备。
• FLÜSSIGKRISTALLANZEIGEN MIT HOMÖOTROPER AUSRICHTUNG
  申请人：Merck Patent GmbH

  公开号：EP2670818B1

  公开（公告）日：2016-10-05
• KAPPA OPIOID AGONISTS AND USES THEREOF
  申请人：Nektar Therapeutics

  公开号：EP3013812A2

  公开（公告）日：2016-05-04